Researchers examine the antibody response to natural infection or COVID-19 vaccination in individuals living with HIV infection.
More companies need to set diversity enrollment goals in cancer trials, FDA says
The FDA released draft guidance back in April 2022 recommending that biopharma sponsors voluntarily submit plans to explain how they plan to enroll their pivotal